Articles tagged with: Leukemia & Lymphoma Society
News»
The Access to Cancer Clinical Trials Act of 2009 was introduced to the Senate on February 26. Clinical trials play a critical role in developing new treatments for many types of cancer, including multiple myeloma. Participation in these trials may also lead to more favorable outcomes for cancer patients.
Currently, group and individual health insurance issuers and group health plans may decide not to cover routine services in clinical trials that they cover in standard therapy under the premise that clinical trials are experimental treatments.
The Access to Cancer Clinical Trials Act …
NewsFlash »
The Road To Discovery: Emerging Therapies In Blood Cancers — The Leukemia & Lymphoma Society (LLS) will host a free patient education program on April 30 from 5:30 p.m. to 7:30 p.m. at The White Inn in Fredonia, NY. The program will discuss how new drugs are discovered, researched, and approved for treatment; recent and ongoing advances in the treatment of blood cancers; and participation in clinical trials as a possible treatment option. Pre-registration for this event is required on or before April 24. For more information, visit the LLS Web site.
Regatta Cup — The 2009 Leukemia Cup Regatta series, sponsored by the Leukemia & Lymphoma Society (LLS), will hold several fundraisers around the country throughout the month of May. Locations include San Diego; Panama City Beach, FL; Carlyle, MO; Southport, NC; and Lake Mission Viejo, CA. The annual Regatta Cup series has raised more than $27 million since its inception in 1988, with the 2008 events raising more than $3.6 million from 38 Regattas.
ARRY-520 Clinical Trials For Multiple Myeloma — Relapsed/refractory multiple myeloma patients are being recruited for a Phase 1/2 trial involving ARRY-520, a drug that prevents cancer cell reproduction. These Phase 1/2 clinical trials will test for safety and tolerability as well as disease response. For more information about the Phase 1/2 study, visit ClinicalTrials Web site. To learn more about ARRY-520, see the press release by ARRAY BioPharma.
For a more detailed listing of myeloma-related events, please check the Myeloma Beacon Events Calendar.
NewsFlash »
Cultural Competency At The Bedside: Breaking Down Barriers To Cancer Care – On April 23, the Leukemia & Lymphoma Society (LLS) and the National Cancer Institute will be holding an educational program on cultural competency for nursing professionals and social workers. The program will be held at Baruch College in New York City and runs from 8 a.m. to 1 p.m. Topics to be discussed include cancer occurrence in different ethnic groups, cultural viewpoints and values, financial difficulties, and helping patients find direction in dealing with cancer care. The program is free, but registration is required by April 20. For more information or to register, please visit the LLS Web site.
Dental Health During Cancer Treatments – CancerCare is sponsoring an educational teleconference workshop on April 24 from 1:30 p.m. to 2:30 p.m. ET. Professionals will discuss dental issues and wellness during cancer treatments. Questions are welcomed and encouraged. There are no participation fees or phone charges, although registration is required. For further information or to register, please see the CancerCare Web site.
Miles For Myeloma 5K Walk/Run – The International Myeloma Foundation (IMF) will be hosting a walk/run event on April 25 in Philadelphia. The event begins at 9 a.m. and the course follows Martin Luther King Drive. Proceeds from this event will benefit myeloma research and patients in need of support. For further information or to register, please visit the IMF Web site.
For a more detailed listing of myeloma-related events, please check the Myeloma Beacon Events Calendar.
NewsFlash »
Boston Marathon — Registration for the 2009 Boston Marathon on April 20 has already closed, but those who are interested in racing or sponsoring entries for multiple myeloma research may attain a charity entry through the MMRF or the IMF. The MMRF requires an online application and a fundraising minimum of $5000. The IMF is sponsoring the Marathon for Mom, which is asking for donations in honor of Gail Pollard, a patient who was recently diagnosed with multiple myeloma. For more information about the Boston Marathon, please visit the Boston Marathon Web site.
The Road To Discovery: Emerging Therapies In Blood Cancers — The Leukemia & Lymphoma Society (LLS) will host a free patient education program on April 21 from 5:30 p.m. to 7:30 p.m. at The Nebraska Medical Center in Omaha, NE. The program will discuss how new drugs are discovered, researched, and approved for treatment; recent and ongoing advances in the treatment of blood cancers; and participation in clinical trials as a possible treatment option. Pre-registration for this event is required. A complimentary dinner will be provided. For more information, visit the LLS Web site.
For a more detailed listing of myeloma-related events, please check the Myeloma Beacon Events Calendar.
NewsFlash »
IMF San Francisco Patient & Family Seminar – On April 17 and 18 the International Myeloma Foundation (IMF) will be hosting an informational seminar at the Hotel Nikko in San Francisco. The seminar will run from 1:00 p.m. to 9:00 p.m. on April 17 and 7:00 a.m. to 5:00 p.m. on April 18. Topics discussed include managing side effects, an overview of myeloma, and current therapies, among others. Registration for the seminar is required and the cost per person ranges from $30 to $60. To find more information on this seminar, please visit the IMF Web site.
100th Annual Meeting Of The American Association For Cancer Research – The American Association for Cancer Research (AACR) will be holding its 100th Annual Meeting April 18-22 at the Colorado Convention Center in Denver. The meeting will focus on the most up-to-date cancer research with leading experts from around the world. For more information or to register for this event, please visit the AACR Web site.
Desert International Triathlon – The 10th Annual Toyota Desert International Triathlon will be held on April 19 at Lake Cahuilla in La Quinta, CA. The Leukemia & Lymphoma Society (LLS) will benefit from funds raised by the hotel accommodations, tickets for the pasta and victory party, and race entry fees. The race will include a 500-meter swim, 14-mile bike, and a 3-mile run. For more information, please visit the LLS Web site.
For a more detailed listing of myeloma-related events, please check the Myeloma Beacon Events Calendar.
News»
On February 28, the third annual Texas Forum on Blood Cancers was held in Dallas. One major topic of the forum was the importance of clinical trials for treating blood cancers such as multiple myeloma.
The Leukemia & Lymphoma Society (LLS) is currently supporting research and clinical trials through its Therapy Acceleration Program, which began in 2008. The program helps fund new research and clinical trials and also joins forces of the private sector and academic researchers.
Clinical trials are important to understanding and fighting any disease. Fredrick B. Hagemeister, MD, professor …
NewsFlash »
Meet The Doctor With Dr. Ikhlaque — This free patient education program, sponsored by the Leukemia & Lymphoma Society (LLS), will be held on April 8, from 6:30 p.m. to 8 p.m. at the Ohio Valley Medical Center in Wheeling, WV. The event will provide current disease and treatment information for blood cancers and management strategies for patients, family members, and caregivers. The program will allow participants to ask questions to experts in the field of medicine and oncology. For more information, visit the LLS Web site.
Milestones In Myeloma Therapy — The Leukemia & Lymphoma Society (LLS) will host a free patient education program on April 13, from 6 p.m. to 8 p.m. at Gilda’s Club in Grand Rapids, MI. The program will cover an overview of multiple myeloma, a review of current and emerging drug therapies, management of disease and treatment-related side effects, as well as emotional aspects and support. The deadline to register for this event is April 10. For more information, visit the LLS Web site.
